Khaled Hosny1,2,3, Hani Asfour4, Waleed Rizg1,2,3, Nabil A Alhakamy1,2,3, Amal Sindi5, Hala Alkhalidi6, Walaa Abualsunun1, Rana Bakhaidar1, Alshaimaa M Almehmady1, Sara Akeel5, Sarah Ali5, Adel Alghaith7, Sultan Alshehri7, Rasha Khallaf8. 1. Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia. 2. Center of Excellence for Drug Research and Pharmaceutical Industries, King Abdulaziz University, Jeddah, 21589, Saudi Arabia. 3. Advanced Drug Delivery Research Group, Faculty of Pharmacy, King Abdulaziz University, Jeddah, 21589, Saudi Arabia. 4. Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah, 21589, Saudi Arabia. 5. Oral diagnostic sciences department, Faculty of Dentistry, King Abdulaziz University, Jeddah, Saudi Arabia. 6. Department of Clinical pharmacy, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia. 7. Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia. 8. Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62511, Egypt.
Abstract
INTRODUCTION: Natural oil-based nanoemulsions (NEs) have been widely investigated in many diseases that affect the oral cavity. NEs are delivery systems that enhance the solubility of lipid therapeutics and improve their delivery to target sites; they are known as self-nanoemulsifying drug delivery systems (SNEDDSs). The current investigation's aim was to produce an oregano essential oil-based nanoemulsion (OEO-SNEDD) that would have antibacterial and antifungal effects against oral microbiota and improve oral health. METHODS: Several OEO-SNEDDSs were developed using different percentages of OEO (10%, 14%, and 18%), percentages of a surfactant mixture Pluracare L64:Lauroglycol FCC (18%, 32%, and 36%), Smix ratios (1:2, 1:1, and 2:1), and hydrophilic-lipophilic balances (HLBs) of the surfactant mixture (8, 10, and 12) using the Box‒Behnken design. The optimized concentration of excipients was determined using a pseudoternary phase diagram to obtain the NEs. The formulations were evaluated for their droplet size, stability index, and antibacterial and antifungal activities. RESULTS: The NEs had a droplet size of 150 to 500 nm and stability index of 47% to 95%, and the produced formulation reached antibacterial and antifungal inhibition zones of up to 19 and 17 mm, respectively. The Box‒Behnken design was adopted to get the optimum formulation, which was 18% OEO, 36% Smix, 10.29 HLB of Smix, and a 1.25:1 Smix ratio. The optimized formulation had a lower ulcer index compared with various other formulations evaluated in rats. CONCLUSION: This study illustrated that OEO-SNEDDSs can provide good protection against oral microbial infections.
INTRODUCTION: Natural oil-based nanoemulsions (NEs) have been widely investigated in many diseases that affect the oral cavity. NEs are delivery systems that enhance the solubility of lipid therapeutics and improve their delivery to target sites; they are known as self-nanoemulsifying drug delivery systems (SNEDDSs). The current investigation's aim was to produce an oregano essential oil-based nanoemulsion (OEO-SNEDD) that would have antibacterial and antifungal effects against oral microbiota and improve oral health. METHODS: Several OEO-SNEDDSs were developed using different percentages of OEO (10%, 14%, and 18%), percentages of a surfactant mixture Pluracare L64:Lauroglycol FCC (18%, 32%, and 36%), Smix ratios (1:2, 1:1, and 2:1), and hydrophilic-lipophilic balances (HLBs) of the surfactant mixture (8, 10, and 12) using the Box‒Behnken design. The optimized concentration of excipients was determined using a pseudoternary phase diagram to obtain the NEs. The formulations were evaluated for their droplet size, stability index, and antibacterial and antifungal activities. RESULTS: The NEs had a droplet size of 150 to 500 nm and stability index of 47% to 95%, and the produced formulation reached antibacterial and antifungal inhibition zones of up to 19 and 17 mm, respectively. The Box‒Behnken design was adopted to get the optimum formulation, which was 18% OEO, 36% Smix, 10.29 HLB of Smix, and a 1.25:1 Smix ratio. The optimized formulation had a lower ulcer index compared with various other formulations evaluated in rats. CONCLUSION: This study illustrated that OEO-SNEDDSs can provide good protection against oral microbial infections.
Authors: Robert D Trim; Michael A Skinner; Mary B Farone; John D Dubois; Anthony L Newsome Journal: Parasitol Res Date: 2011-03-12 Impact factor: 2.289
Authors: Wai-Ting Chong; Chin-Ping Tan; Yoke-Kqueen Cheah; Ahmad Firdaus B Lajis; Noor Lida Habi Mat Dian; Sivaruby Kanagaratnam; Oi-Ming Lai Journal: PLoS One Date: 2018-08-24 Impact factor: 3.240
Authors: Waleed Y Rizg; Khaled M Hosny; Bayan A Eshmawi; Abdulmohsin J Alamoudi; Awaji Y Safhi; Samar S A Murshid; Fahad Y Sabei; Adel Al Fatease Journal: Polymers (Basel) Date: 2022-05-07 Impact factor: 4.967
Authors: Sarah A Ali; Nabil A Alhakamy; Khaled M Hosny; Eman Alfayez; Deena M Bukhary; Awaji Y Safhi; Moutaz Y Badr; Rayan Y Mushtaq; Majed Alharbi; Bader Huwaimel; Mohammed Alissa; Sameer Alshehri; Ali H Alamri; Taha Alqahtani Journal: Drug Deliv Date: 2022-12 Impact factor: 6.819
Authors: Waleed Y Rizg; Khaled M Hosny; Samar S Elgebaly; Abdulmohsin J Alamoudi; Raed I Felimban; Hossam H Tayeb; Majed Alharbi; Haitham A Bukhary; Walaa A Abualsunun; Alshaimaa M Almehmady; Rasha A Khallaf Journal: Pharmaceutics Date: 2021-12-14 Impact factor: 6.321
Authors: Waleed Y Rizg; Khaled M Hosny; Samar S Mahmoud; Ahmed K Kammoun; Abdulmohsin J Alamoudi; Hossam H Tayeb; Haitham A Bukhary; Moutaz Y Badr; Samar S A Murshid; Eman Alfayez; Sarah A Ali; Rayan Y Mushtaq; Walaa A Abualsunun Journal: Gels Date: 2022-03-12